SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BRESAGEN LIMITED (BGN)

Delisted from ASX 08/01/2007

SHARE PRICES

(discontinued 17 July 2020)

Former (or subsequent) names

 

Shareholder links

Our website ranking of BGN: rating 1
(1 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare, Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details

Address: 8 Dalgleish Street, THEBARTON , SA, AUSTRALIA, 5031
Tel:  08 8234 2660 Fax: 08 8234 6268

Date first listed: 21/09/1999
Company Secretary: Mr Bryan Dulhunty
Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Biotechnology company engaged in the commercial development of protein and peptide therapeutics

delisted under listing rule 17.14 following compulsory acquisition by Hospira Holdings (S.A.) Pty Ltd

08/01/2007

we understand Hospira was successful with an offer of 14 cents cash per share - the price offered by Hospira for each BresaGen Option was equal to the difference between the 14 cents per share cash offer price under the Offer and the exercise price of each BresaGen Option held and optionholders were contacted separately

08/01/2007

former shareholders in this company may have unclaimed money arising from the compulsory acquisition of their shares - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service

08/01/2007

releases a Notice of right of buy out to holders of convertible securities following a takeover bid and a copy of the independent expert's report

23/11/2006

shares suspended from quotation

26/10/2006

shares reinstated to quotation

11/08/2006

shares suspended from quotation pending release of an announcement

08/08/2006

shares reinstated to quotation

13/12/2004

administrators advise that the DOCA is fully effectuated and control is in the hands of the directors elected at the meeting on 11 October

14/10/2004

shareholders approve the issue of shares to CBio and elect three directors

11/10/2004

meeting called for 11 October to approve the CBio arrangements

09/09/2004

now announces that merged Cythera entity has in turn merged with Novocell Inc, a California-based company - what all this means for shareholders will hopefully be revealed in the fullness of time - shareholder documents (for a meeting etc) are to be sent shortly

02/09/2004

advises that merger of its US subsidiary with San Diego based Cythera Inc is complete

09/07/2004

company announces documents have been signed paving the way for a merger of its US subsidiary with San Diego based Cythera Inc

31/05/2004

executes a Deed of Company arrangement with CBio Limited for the restructure and re-listing of the company

24/05/2004

administrators advise they have reached in-principle agreement for the restructuring and relisting of the company - while creditors may receive 100 cents in the dollar it will be interesting to see if there is any residual value for shareholders

02/04/2004

administrators advise they are currently in the process of assessing the offers they have received for the assets/business of the company

10/03/2004

B Carter and M Lewis of Ferrier Hodgson appointed voluntary administrators

20/01/2004

shares suspended from quotation

20/01/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Michael MonsourNon Exec Director
    Wolf HanischDirector
    Stephen JonesDirector
    Meera VermaDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.